X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (78) 78
humans (70) 70
oncology (48) 48
male (45) 45
child (41) 41
female (36) 36
adolescent (32) 32
cancer (28) 28
child, preschool (28) 28
children (25) 25
pediatrics (23) 23
tumors (18) 18
infant (17) 17
prognosis (17) 17
cell line, tumor (16) 16
chemotherapy (16) 16
adult (15) 15
medulloblastoma (15) 15
hematology (14) 14
analysis (13) 13
immunohistochemistry (13) 13
animals (12) 12
therapy (12) 12
cancer research (11) 11
expression (11) 11
leukemia (11) 11
treatment outcome (11) 11
neuroblastoma (10) 10
research (10) 10
blasting (9) 9
care and treatment (9) 9
childhood (9) 9
gene expression (9) 9
genetic aspects (9) 9
health aspects (9) 9
heating (9) 9
human necessities (9) 9
lighting (9) 9
mechanical engineering (9) 9
medical prognosis (9) 9
weapons (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
apoptosis (8) 8
cell biology (8) 8
engine plants in general (8) 8
machines or engines in general (8) 8
neoplasms - drug therapy (8) 8
osteosarcoma (8) 8
pathology (8) 8
proteins (8) 8
steam engines (8) 8
breast-cancer (7) 7
celecoxib (7) 7
clinical neurology (7) 7
drug therapy (7) 7
medulloblastoma - genetics (7) 7
pharmacology & pharmacy (7) 7
rhabdomyosarcoma (7) 7
young adult (7) 7
abstracts (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
biomarkers, tumor - metabolism (6) 6
biomedicine (6) 6
brain neoplasms - genetics (6) 6
brain neoplasms - pathology (6) 6
cells (6) 6
combined modality therapy (6) 6
methotrexate (6) 6
metronomic chemotherapy (6) 6
mutation (6) 6
oxidative stress (6) 6
performing operations (6) 6
poor-prognosis (6) 6
resistance (6) 6
transporting (6) 6
acute lymphoblastic leukemia (5) 5
acute lymphoblastic-leukemia (5) 5
aged (5) 5
all-trans retinoic acid (5) 5
biology (5) 5
brain-tumors (5) 5
breast cancer (5) 5
cancer therapies (5) 5
cell differentiation (5) 5
clinical trials (5) 5
combustion engines (5) 5
cyclically operating valves for machines or engines (5) 5
dna-binding proteins - metabolism (5) 5
follow-up studies (5) 5
gene (5) 5
genetics (5) 5
glioblastoma multiforme (5) 5
hot-gas or combustion-product engine plants (5) 5
medicine & public health (5) 5
medicine, research & experimental (5) 5
medulloblastoma - pathology (5) 5
middle aged (5) 5
multidisciplinary sciences (5) 5
nestin (5) 5
physiological aspects (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Thompson, Eric M, MD and Hielscher, Thomas, MSc and Bouffet, Eric, Prof and Remke, Marc, MD and Luu, Betty, BSc and Gururangan, Sridharan, Prof and McLendon, Roger E, Prof and Bigner, Darell D, Prof and Lipp, Eric S, MD and Perreault, Sebastien, MD and Cho, Yoon-Jae, MD and Grant, Gerald, MD and Kim, Seung-Ki, Prof and Lee, Ji Yeoun, MD and Rao, Amulya A Nageswara, MD and Giannini, Caterina, Prof and Li, Kay Ka Wai, MD and Ng, Ho-Keung, Prof and Yao, Yu, MD and Kumabe, Toshihiro, MD and Tominaga, Teiji, Prof and Grajkowska, Wieslawa A, Prof and Perek-Polnik, Marta, Prof and Low, David C Y, MBBCh and Seow, Wan Tew, MBBS and Chang, Kenneth T E, MBBCh and Mora, Jaume, Prof and Pollack, Ian F, Prof and Hamilton, Ronald L, MD and Leary, Sarah, MD and Moore, Andrew S, PhD and Ingram, Wendy J, PhD and Hallahan, Andrew R, MBBS and Jouvet, Anne, MD and Fèvre-Montange, Michelle, PhD and Vasiljevic, Alexandre, MD and Faure-Conter, Cecile, MD and Shofuda, Tomoko, PhD and Kagawa, Naoki, MD and Hashimoto, Naoya, MD and Jabado, Nada, MD and Weil, Alexander G, MD and Gayden, Tenzin, PhD and Wataya, Takafumi, MD and Shalaby, Tarek, MD and Grotzer, Michael, Prof and Zitterbart, Karel, PhD and Sterba, Jaroslav, Prof and Kren, Leos, MD and Hortobágyi, Tibor, Prof and Klekner, Almos, PhD and László, Bognár, Prof and Pócza, Tímea, MSc and Hauser, Peter, MD and Schüller, Ulrich, MD and Jung, Shin, Prof and Jang, Woo-Youl, MD and French, Pim J, Prof and Kros, Johan M, Prof and van Veelen, Marie-Lise C, MD and Massimi, Luca, MD and Leonard, Jeffrey R, Prof and Rubin, Joshua B, MD and Vibhakar, Rajeev, MD and Chambless, Lola B, MD and Cooper, Michael K, MD and Thompson, Reid C, Prof and Faria, Claudia C, MD and Carvalho, Alice, MD and Nunes, Sofia, MD and Pimentel, José, MD and Fan, Xing, MD and Muraszko, Karin M, Prof and López-Aguilar, Enrique, MD and Lyden, David, Prof and Garzia, Livia, PhD and Shih, David J H, PhD and Kijima, Noriyuki, MD and Schneider, Christian, MD and Adamski, Jennifer, PhD and Northcott, Paul A, PhD and Kool, Marcel, PhD and Jones, David T W, PhD and Chan, Jennifer A, MD and Nikolic, Ana, MD and Garre, Maria Luisa, MD and Van Meir, Erwin G, Prof and Osuka, Satoru, MD and Olson, Jeffrey J, Prof and Jahangiri, Arman, BSc and Castro, Brandyn A, BSc and Gupta, Nalin, MD and Weiss, William A, Prof and Moxon-Emre, Iska, MSc and Mabbott, Donald J, PhD and Lassaletta, Alvaro, MD and Hawkins, Cynthia E, Prof and Tabori, Uri, MD and Drake, James, Prof and Kulkarni, Abhaya, Prof and ...
The Lancet Oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 484 - 495
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 03/2018, Volume 364, Issue 3, pp. 433 - 446
Journal Article
by Northcott, Paul A and Lee, Catherine and Zichner, Thomas and Stütz, Aian M and Erkek, Serap and Kawauchi, Daisuke and Shih, David J. H and Hovestadt, Volker and Zapatka, Marc and Sturm, Dominik and Jones, David T. W and Kool, Marcel and Remke, Marc and Cavalli, Florence M. G and Zuyderduyn, Scott and Bader, Gary D and VandenBerg, Scott and Esparza, Lourdes Aiana and Ryzhova, Marina and Wang, Wei and Wittmann, Anea and Stark, Sebastian and Sieber, Laura and Seker-Cin, Huriye and Linke, Linda and Kratochwil, Fabian and Jäger, Natalie and Buchhalter, Ivo and Imbusch, Charles D and Zipprich, Gideon and Raeder, Benjamin and Schmidt, Sabine and Diessl, Nicolle and Wolf, Stephan and Wiemann, Stefan and Brors, Benedikt and Lawerenz, Chris and Eils, Jürgen and Warnatz, Hans-Jörg and Risch, Thomas and Yaspo, Marie-Laure and Weber, Ursula D and Bartholomae, Cynthia C and von Kalle, Christof and Turányi, Eszter and Hauser, Peter and Sanden, Emma and Darabi, Anna and Siesjö, Peter and Sterba, Jaroslav and Zitterbart, Karel and Sumerauer, David and van Sluis, Peter and Versteeg, Rogier and Volckmann, Richard and Koster, Jan and Schuhmann, Martin U and Ebinger, Martin and Grimes, H. Leighton and Robinson, Giles W and Gajjar, Amar and Mynarek, Martin and von Hoff, Katja and Rutkowski, Stefan and Pietsch, Torsten and Scheurlen, Wolfram and Felsberg, Jörg and Reifenberger, Guido and Kulozik, Aneas E and von Deimling, Aneas and Witt, Olaf and Eils, Roland and Gilbertson, Richard J and Korshunov, Aney and Taylor, Michael D and Lichter, Peter and Korbel, Jan O and Wechsler-Reya, Robert J and Pfister, Stefan M and Neurosurgery and Neurokirurgi and Lund University and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Lunds universitet
Nature, ISSN 0028-0836, 2014, Volume 511, Issue 7510, pp. 428 - 434
Journal Article
by Morrissy, A. Sorana and Garzia, Livia and Shih, David J. H and Zuyderduyn, Scott and Huang, Xi and Skowron, Patryk and Remke, Marc and Cavalli, Florence M. G and Ramaswamy, Vijay and Lindsay, Patricia E and Jelveh, Salomeh and Donovan, Laura K and Wang, Xin and Luu, Betty and Zayne, Kory and Li, Yisu and Mayoh, Chelsea and Thiessen, Nina and Mercier, Eloi and Mungall, Karen L and Ma, Yusanne and Tse, Kane and Zeng, Thomas and Shumansky, Karey and Roth, Andrew J. L and Shah, Sohrab and Farooq, Hamza and Kijima, Noriyuki and Holgado, Borja L and Lee, John J. Y and Matan-Lithwick, Stuart and Liu, Jessica and Mack, Stephen C and Manno, Alex and Michealraj, K.A and Nor, Carolina and Peacock, John and Qin, Lei and Reimand, Juri and Rolider, Adi and Thompson, Yuan Y and Wu, Xiaochong and Pugh, Trevor and Ally, Adrian and Bilenky, Mikhail and Butterfield, Yaron S. N and Carlsen, Rebecca and Cheng, Young and Chuah, Eric and Corbett, Richard D and Dhalla, Noreen and He, An and Lee, Darlene and Li, Haiyan I and Long, William and Mayo, Michael and Plettner, Patrick and Qian, Jenny Q and Schein, Jacqueline E and Tam, Angela and Wong, Tina and Birol, Inanc and Zhao, Yongjun and Faria, Claudia C and Pimentel, José and Nunes, Sofia and Shalaby, Tarek and Grotzer, Michael and Pollack, Ian F and Hamilton, Ronald L and Li, Xiao-Nan and Bendel, Anne E and Fults, Daniel W and Walter, Andrew W and Kumabe, Toshihiro and Tominaga, Teiji and Collins, V. Peter and Cho, Yoon-Jae and Hoffman, Caitlin and Lyden, David and Wisoff, Jeffrey H and Garvin, James H and Stearns, Duncan S and Massimi, Luca and Schüller, Ulrich and Sterba, Jaroslav and Zitterbart, Karel and Puget, Stephanie and Ayrault, Olivier and Dunn, Sandra E and Tirapelli, Daniela P. C and Carlotti, Carlos G and Wheeler, Helen and Hallahan, Andrew R and Ingram, Wendy and MacDonald, Tobey J and Olson, Jeffrey J and Van Meir, Erwin G and Lee, Ji-Yeoun and Wang, Kyu-Chang and ...
Nature, ISSN 0028-0836, 01/2016, Volume 529, Issue 7586, pp. 351 - 357
The development of targeted anti-cancer therapies through the study of cancer genomes is intended to increase survival rates and decrease treatment-related... 
HETEROGENEITY | CANCER EVOLUTION | CELLS | IMPACT | MULTIDISCIPLINARY SCIENCES | SUBGROUP MEDULLOBLASTOMA | DYNAMICS | MUTATIONS | SEQUENCING DATA | LYMPHOBLASTIC-LEUKEMIA | GENOME | Clone Cells - drug effects | Humans | Male | Medulloblastoma - therapy | Radiotherapy, Image-Guided | Selection, Genetic - drug effects | Drosophila melanogaster - genetics | Neoplasm Recurrence, Local - pathology | Medulloblastoma - radiotherapy | DNA Mutational Analysis | Medulloblastoma - pathology | Female | Medulloblastoma - surgery | Cerebellar Neoplasms - pathology | Medulloblastoma - genetics | Molecular Targeted Therapy - methods | Disease Models, Animal | Signal Transduction | Neoplasm Recurrence, Local - therapy | Drosophila melanogaster - cytology | Cerebellar Neoplasms - genetics | Clone Cells - metabolism | Genome, Human - genetics | Xenograft Model Antitumor Assays | Animals | Clone Cells - pathology | Craniospinal Irradiation | Neoplasm Recurrence, Local - genetics | Mice | Cerebellar Neoplasms - therapy | Cerebellar Neoplasms - surgery | Cerebellar Neoplasms - radiotherapy | Clonal selection theory | Care and treatment | Medulloblastoma | Oncology, Experimental | Genetic aspects | Research | Cancer | Genes | Cloning | Clinical trials | Cytotoxicity | Genomes | Radiation therapy | Metastasis | Cancer therapies | Rodents | Medical prognosis | Mutation | Tumors | Index Medicus
Journal Article
Journal Article
Heart, ISSN 1355-6037, 05/2019, Volume 105, Issue Suppl 6, p. A67
IntroductionAnthracyclines (ANT; e.g. doxorubicin, epirubucin or daunorubicin) are still indispensable part of modern chemotherapy regiments, despite of their... 
Heart failure | Cardiomyocytes
Journal Article
Journal Article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 03/2018, Volume 364, Issue 3, pp. 433 - 446
Dexrazoxane (DEX), the only cardioprotectant approved against anthracycline cardiotoxicity, has been traditionally deemed to be a prodrug of the iron-chelating... 
AGENT | RING OPEN METABOLITES | CANCER-PATIENTS | RAT | ICRF-187 | CHRONIC ANTHRACYCLINE CARDIOTOXICITY | IN-VIVO | HYDROLYSIS | PHARMACOLOGY & PHARMACY | PHASE-I | CHELATING FORM | Index Medicus
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 09/2018, Volume 19, Issue 9, p. 2599
Infantile myofibromatosis represents one of the most common proliferative fibrous tumors of infancy and childhood. More effective treatment is needed for... 
Sunitinib | FR180204 | Erlotinib | Targeted therapy | Platelet-derived growth factor receptor | Protein kinase inhibitors | Infantile myofibromatosis | Receptor tyrosine kinases | U0126 | sunitinib | targeted therapy | ACTIVATION | protein kinase inhibitors | erlotinib | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CHEMISTRY, MULTIDISCIPLINARY | CHILDREN | receptor tyrosine kinases | SIGNALING PATHWAY | ROLES | RECURRENT | GROWTH | infantile myofibromatosis | platelet-derived growth factor receptor | RESISTANCE | EXPRESSION | Pyrazoles - therapeutic use | Humans | Myofibromatosis - drug therapy | Infant | Male | Receptor, Platelet-Derived Growth Factor beta - genetics | Nitriles - administration & dosage | Pyridazines - administration & dosage | Female | Phosphorylation - drug effects | Sunitinib - administration & dosage | Child | Pyridazines - therapeutic use | Receptor, Platelet-Derived Growth Factor beta - metabolism | Erlotinib Hydrochloride - administration & dosage | Myofibromatosis - congenital | Myofibromatosis - genetics | Protein Kinase Inhibitors - administration & dosage | Pyrazoles - administration & dosage | Sunitinib - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Butadienes - administration & dosage | Cell Line, Tumor | Butadienes - therapeutic use | Cell Proliferation - drug effects | Erlotinib Hydrochloride - therapeutic use | Mutation | Nitriles - therapeutic use | Cell proliferation | Tyrosine | Phosphorylation | Platelet-derived growth factor | Tumor cells | Cyclin-dependent kinases | Extracellular signal-regulated kinase | MAP kinase | Tumor cell lines | Drug resistance | Kinases | Proteins | Inhibitors | Protease inhibitors | Protein-tyrosine kinase receptors | Children | Growth factors | Protein-tyrosine kinase | Tumors | Pediatrics | Oncology | Phosphatase | Signal transduction | Cell growth | Studies | Medical prognosis | Cancer | Index Medicus
Journal Article
13.